Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092063 · ClinicalTrials.gov registry record · NA
Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03092063: Completed NA study, sponsored by University of California, Los Angeles.
NCT03092063 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 330 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03092063, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The overall objective of this study is to construct an adaptive intervention that integrates family members and patients as partners in care while promoting diabetes self-management for Mexican Americans with Type 2 diabetes. The project incorporates four evidence-based, culturally tailored treatments using a Sequential, Multiple Assignment Randomized Trial to help determine what sequence of intervention strategies work most efficiently and for whom.
Primary Outcome
This 11-item scale assesses ADA-recommended health activities in diet, exercise, glucose self-monitoring, medication adherence and foot care. The mean number of days in the past week that activities are performed is calculated on a scale of 0-7; a high mean score indicates better diabetes self-management.
Interventions
- BEHAVIORAL Tomando Control-Nurse
- BEHAVIORAL Tomando Control-Promotora
- BEHAVIORAL Enhanced engagement
- BEHAVIORAL Multifamily Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT03092063 record still lists
NCT03092063 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 4 interventions - of which Tomando Control-Nurse is the first listed.
NCT03092063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03092063 about?
NCT03092063 is a clinical study titled "Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes". The overall objective of this study is to construct an adaptive intervention that integrates family members and patients as partners in care while promoting diabetes self-management for Mexican Americans with Type 2 diabetes. The project incorporates four evidence-based, culturally tailored treatmen...
What is the current status of trial NCT03092063?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2017-03-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03092063?
The interventions under investigation include: Tomando Control-Nurse (BEHAVIORAL), Tomando Control-Promotora (BEHAVIORAL), Enhanced engagement (BEHAVIORAL), Multifamily Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092063?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03092063's enrollment target sits among peer trials
330 307th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI